drug delivery platform

Intrommune Therapeutics is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy. Its core technology delivers immunotherapeutic agents in a specially formulated toothpaste designed to incorporate and stabilize allergenic proteins, a new approach for treating peanut and other food allergies. This approach is called oral mucosal immunotherapy (OMIT), delivering allergenic proteins to the oral cavity to potentially drive immune tolerance without ingesting the allergen.

Read more

allergy immunotherapyoral mucosal immunotherapy (OMIT)